Companies / Japan
GSK To Boost Japan Launches
June 2006 | Company Finance AlertAccording to international reports, UK drug major GlaxoSmithKline (GSK) is to increase launches of new products in Japan, aiming to boost sales by 10% per year. With local revenues of JPY186.6bn (US$1.62bn) in 2005, the Japanese subsidiary is currently ranked only ninth, although its parent is the world's second largest drugmaker by sales. GSK now hopes to be ranked fifth in Japan by the end of the decade.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
